SeqOne
SeqOne is a genomics technology company providing an AI-powered bioinformatics platform designed to accelerate and enhance personalized medicine through next-generation sequencing (NGS) data analysis. Their platform supports molecular labs worldwide by streamlining germline and somatic genomic analyses across various sequencing types, including panels, exomes, and genomes, and is compatible with multiple sequencing technologies. Key products include the SeqOne Platform, an in vitro diagnostic medical device with CE-IVD Class C certification, featuring AI-driven variant ranking (DiagAI Score), automated data pipelines (SeqOne Flow), and premium clinical-grade annotation integrating top-tier databases like CKB and COSMIC. The company serves over 140 clinical and research labs in 20+ countries, supporting 50,000+ genomic tests annually with clinical-grade accuracy. SeqOne's business model is pay-per-analysis with transparent pricing and no volume constraints. The company is expanding globally, including the US market, and has recently acquired Life & Soft to enhance multi-omics capabilities. SeqOne is ISO 13485 certified for medical device manufacturing and ensures data security with patented double-encryption and hosting on ISO 27001-certified platforms. Their platform is widely adopted in oncology and rare disease diagnostics, with strategic collaborations and strong customer testimonials highlighting its reliability, precision, and user-friendly design.
SeqOne
SeqOne is a genomics technology company providing an AI-powered bioinformatics platform designed to accelerate and enhance personalized medicine through next-generation sequencing (NGS) data analysis. Their platform supports molecular labs worldwide by streamlining germline and somatic genomic analyses across various sequencing types, including panels, exomes, and genomes, and is compatible with multiple sequencing technologies. Key products include the SeqOne Platform, an in vitro diagnostic medical device with CE-IVD Class C certification, featuring AI-driven variant ranking (DiagAI Score), automated data pipelines (SeqOne Flow), and premium clinical-grade annotation integrating top-tier databases like CKB and COSMIC. The company serves over 140 clinical and research labs in 20+ countries, supporting 50,000+ genomic tests annually with clinical-grade accuracy. SeqOne's business model is pay-per-analysis with transparent pricing and no volume constraints. The company is expanding globally, including the US market, and has recently acquired Life & Soft to enhance multi-omics capabilities. SeqOne is ISO 13485 certified for medical device manufacturing and ensures data security with patented double-encryption and hosting on ISO 27001-certified platforms. Their platform is widely adopted in oncology and rare disease diagnostics, with strategic collaborations and strong customer testimonials highlighting its reliability, precision, and user-friendly design.
